Groton Biosystems releases in-situ filter sampling probe for automated, manual extraction of cell-free samples

NewsGuard 100/100 Score

Groton Biosystems, the leader in automated online bioprocess sampling, has announced the release of a sterilizable, disposable in-situ filter sampling probe for automated and manual extraction of cell-free samples. The rugged design of this product delivers extended service life in typical bioreactor applications and features a nonbinding inert surface which resists clogging throughout the extended process runtimes most often associated with cell culture and perfusion applications. The probe is well suited for applications such as mammalian cell culture, E.coli, yeast, both aerobic and anaerobic cultures, other bacterial fungi, algae, and insect cell cultures.

“Cell free samples can be drawn from the vessel using traditional manual sampling techniques or with the Groton Biosystems' ARS-M™ auto sampler. Either way it is a win/win as it improves productivity and reduces risk.”

"This new product simplifies the analysis of samples by eliminating filtration or centrifugation while reducing the risk of contamination." said Bill Dinardo, CEO of Groton Biosystems. "Cell free samples can be drawn from the vessel using traditional manual sampling techniques or with the Groton Biosystems' ARS-M™ auto sampler. Either way it is a win/win as it improves productivity and reduces risk."

Source:

 Groton Biosystems

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
First-of-its-kind AI tool predicts patient response to cancer drugs at single-cell resolution